SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,152.64 -675.61
( -0.90%)

Global Indices

Nasdaq

51,527.73 -356.96
(-0.69%)

Dow Jones

7,726.85 -58.79
(-0.76%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,716.75 8.42
(0.08%)

Forex

USD-INR

95.65 -0.17
(-0.17%)

EUR-INR

109.56 -0.37
(-0.34%)

GBP-INR

127.74 -0.44
(-0.34%)

JPY-INR

0.61 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

79.7352476

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

109.64

5336.87

EPS(TTM)

Face Value()

Div & Yield %

3.74

0.14

Back

Gujarat Themis Biosyn standalone net profit rises 22.19% in the June 2026 quarter

Aug 07,2026

Net profit of Gujarat Themis Biosyn rose 22.19% to Rs 11.07 crore in the quarter ended June 2026 as against Rs 9.06 crore during the previous quarter ended June 2025. Sales rose 22.08% to Rs 43.79 crore in the quarter ended June 2026 as against Rs 35.87 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	43.79	35.87	22
OPM %	47.50	38.81	-
PBDT	19.14	14.15	35
PBT	15.17	12.12	25
NP	11.07	9.06	22

74,152.64 -675.61 ( -0.90%)

51,527.73 -356.96 (-0.69%)

7,726.85 -58.79 (-0.76%)

65,040.24 903.99 (1.41%)

10,716.75 8.42 (0.08%)

95.65 -0.17 (-0.17%)

109.56 -0.37 (-0.34%)

127.74 -0.44 (-0.34%)

0.61 0.00 (-0.29%)